About Jonathan Mow
Form D filings for Veralox Therapeutics in 2023 list Jonathan Mow as chief executive officer and director.
Jonathan Mow first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Jonathan Mow in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jonathan Mow works with at each company, as listed on that company's latest Form D.
Veralox Therapeutics Inc. · Form D, Jun 21, 2023
MK
Megan Krench
Director
AM
Alex Martin
Director
BS
Benjamin Scruggs
Director
JS
Jamie Stiff
Director
KE
Katie Ellias
Director